This bill prohibits a health plan company from restricting an enrollee’s choice regarding where the enrollee receives services for the diagnosis, monitoring, and treatment of a rare disease or condition, and prohibits cost-sharing or limitations on diagnosing or treating a rare disease or condition that place a greater financial burden on the enrollee or are more restrictive than requirements for in-network care. It also requires medical assistance coverage for diagnosis, monitoring, and treating a rare disease or condition to comply with these requirements.